The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Telisotuzumab vedotin monotherapy in patients with previously treated c-Met–overexpressing non-squamous EGFR wildtype advanced NSCLC: Primary analysis of the LUMINOSITY trial.
 
David Ross Camidge
Honoraria - Abbvie; Amgen Astellas BioPharma; Anheart Therapeutics; Apollomics; AstraZeneca; BeiGene; BeiGene; bio-thera; Daiichi Sankyo; Dizal Pharma; Elevation Oncology; EMD Serono; Helsinn Therapeutics; Hengrui Pharmaceutical; Hummingbird; Janssen; Kestrel Labs; Lilly; Mersana; Mirati Therapeutics; nalo therapeutics; Nuvalent, Inc.; OnKure; Puma Biotechnology; Ribon Therapeutics; Roche; Sanofi; Seagen; takeda; Turning Point Therapeutics
Research Funding - Inivata (Inst)
 
Jair Bar
Stock and Other Ownership Interests - Causalis
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pfizer; Roche; Takeda
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Immunai (Inst); MSD (Inst); Novartis (Inst); Oncohost (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Hidehito Horinouchi
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Merck Serono; MSD Oncology; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Novocure; Seagen; Yuhan
Research Funding - A2 Healthcare (Inst); Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BMKK (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Jonathan W. Goldman
Consulting or Advisory Role - AbbVie; AstraZeneca; Bristol-Myers Squibb; Genentech; Gritstone Bio; Janssen; Jazz Pharmaceuticals; Lilly; Pfizer; Puma Biotechnology; Regeneron; Turning Point Therapeutics
Research Funding - Abbvie (Inst); Advaxis (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)
 
Fedor Vladimirovich Moiseenko
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novartis
Speakers' Bureau - AstraZeneca, Takeda, Lilly, Boehringer Ingelheim, BMS, Roche
Research Funding - BIOCAD
Travel, Accommodations, Expenses - Boehringer Ingelheim, Pfizer, Takeda, Sanofi
Other Relationship - Educational activities: AstraZeneca; Educational activities: BMS; Educational activities: MSD; Educational activities: Pfizer; Educational activities: Roche
 
Elena Filippova
Research Funding - AbbVie, MSD, Takeda, AstraZeneca, Novartis, BMS, Mirati Therapeutics (Inst)
 
Irfan Cicin
Consulting or Advisory Role - Abbvie (Inst); Abdi Ibrahim (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Gen (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Lilly (Inst); MSD Oncology (Inst); Nobelpharma (Inst); Novartis/Ipsen (Inst); Pfizer (Inst); Roche (Inst); SERVIER (Inst); Takeda (Inst); Teva
Speakers' Bureau - Abdi Ibrahim (Inst); Astellas Pharma; Bristol-Myers Squibb (Inst); Gen (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Teva (Inst)
 
Tudor Eliade Ciuleanu
No Relationships to Disclose
 
Nathalie Daaboul
Consulting or Advisory Role - AstraZeneca, BMS, Eisai, Merck, Pfizer, Novartis, Roche, Taiho, Takeda
 
Chunling Liu
No Relationships to Disclose
 
Penelope Ann Bradbury
(OPTIONAL) Uncompensated Relationships - Abbvie; Bristol-Myers Squibb; Merck; Mirati Therapeutics
 
Mor Moskovitz
Honoraria - Abbvie; AstraZeneca; BMSi; Johnson & Johnson/Janssen; MSD; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; JNJ; MSD Oncology; Novartis; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - MSD; Pfizer
 
Nuran Katgi
No Relationships to Disclose
 
Pascale Tomasini
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol Myers Squibb Foundation; Janssen; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb/Pfizer; Takeda
 
Alona Zer
Stock and Other Ownership Interests - Nixio
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; MSD; Oncohost; Oncotest/Rhenium; Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche
Other Relationship - Beyond Air
 
Jim Looman
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Christine Ratajczak
Employment - Abbvie
Stock and Other Ownership Interests - AbbVie
 
Martha Li
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Summer Xia
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Shun Lu
Leadership - Innovent BIOLOGICS, INC
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; InventisBio Co. Ltd; Menarini; Pfizer; Roche; Simcere; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh Pharma; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca (Inst); BeiGene (Inst); BMS (Inst); Hansoh (Inst); Hengrui Therapeutics (Inst); Hutchison MediPharma (Inst); Lilly Suzhou Pharmaceutical Co. (Inst); Roche (Inst)